Paula R. Clemens

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.610Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Findings from the Longitudinal CINRG Becker Natural History Study

Journal of Neuromuscular Diseases(2023)10.3233/jnd-230178

Top 32%

0.610DataRank

Top 32%9 citations

Heather Gordish‐Dressman, Gabriela Niizawa, Ksenija Gorni, Michela Guglieri, Anne M. Connolly +15 more

Papers

Driven by 14 papers — median percentile 68. Top paper: “Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial”.

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

The Lancet Neurology(2021)10.1016/s1474-4422(21)00241-6

N/A

2.9DataRank · unranked

185 citations

Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub +95 more

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.44178

N/A

2.0DataRank · unranked

89 citations

Paula R. Clemens, Michela Guglieri, Edward C. Smith, Richard S. Finkel, M. Tulinius +92 more

Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy

Neurology(2024)10.1212/wnl.0000000000208112

N/A

1.5DataRank · unranked

71 citations

Jesse M. Damsker, Michela Guglieri, Paula R. Clemens, Seth J. Perlman, Edward C. Smith +39 more

104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)

Journal of Neurology(2024)10.1007/s00415-024-12236-0

N/A

0.803DataRank · unranked

28 citations

Priya S. Kishnani, Drago Bratkovic, Barry J. Byrne, Kristl G. Claeys, Jordi Díaz‐Manera +79 more

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study

PLoS Medicine(2020)10.1371/journal.pmed.1003222

N/A

0.729DataRank · unranked

82 citations

Laurie S. Conklin, Eric P. Hoffman, Paula R. Clemens, Jean K. Mah, Richard S. Finkel +22 more

Findings from the Longitudinal CINRG Becker Natural History Study

Journal of Neuromuscular Diseases(2023)10.3233/jnd-230178

Top 32%

0.610DataRank

Top 32%9 citations

Heather Gordish‐Dressman, Gabriela Niizawa, Ksenija Gorni, Michela Guglieri, Anne M. Connolly +15 more

Return of participant-level clinical trial results to participants: pilot of a simplified centralised approach

BMJ Open(2024)10.1136/bmjopen-2023-080097

N/A

0.104DataRank · unranked

1 citations

Suzanne Gaglianone, Rahel Ketema, Wangshu Tu, Holly L. Peay, Paula R. Clemens +3 more

Associations between lower extremity muscle fat fraction and motor performance in myotonic dystrophy type 2: A pilot study

Muscle & Nerve(2023)10.1002/mus.27821

N/A

0DataRank · unranked

8 citations

Rebecca A. Knapp, Delanie Lynch, Paula R. Clemens, Ashley A. Weaver, Araya Puwanant +1 more

Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy

Value in Health(2021)10.1016/j.jval.2021.05.016

N/A

0DataRank · unranked

12 citations

Joel Iff, Erik Henricson, V. Vishwanathan, S. Chidambaranathan, W. Douglas Biggar +33 more

Adrenal Suppression From Vamorolone and Prednisone in Duchenne Muscular Dystrophy: Results From the Phase 2b Clinical Trial

The Journal of Clinical Endocrinology & Metabolism(2024)10.1210/clinem/dgae521

N/A

0DataRank · unranked

16 citations

Rebecca Tobin, Utkarsh J. Dang, Raoul Rooman, Michela Guglieri, Paula R. Clemens +3 more

The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy

Journal of Neuromuscular Diseases(2024)10.3233/jnd-230129

N/A

0DataRank · unranked

4 citations

Daniele Sabbatini, Aurora Fusto, Domenico Gorgoglione, Giovanni Umberto Borin, Martina Penzo +34 more

Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy

The Journal of Clinical Pharmacology(2024)10.1002/jcph.2446

N/A

0DataRank · unranked

2 citations

Daniele Sabbatini, Elena Pegoraro, Luca Bello, Paula R. Clemens, Michela Guglieri +7 more

Exposure-response of serum biomarkers to vamorolone, a dissociative corticosteroidal anti-inflammatory drug, in 4- to <7-year children

Steroids(2025)10.1016/j.steroids.2025.109721

N/A

0DataRank · unranked

0 citations

Utkarsh J. Dang, Michael Ziemba, Yetrib Hathout, Paula R. Clemens, Jesse M. Damsker +17 more

Antigen-driven T cell-macrophage interactions mediate the interface between innate and adaptive immunity in histidyl-tRNA synthetase-induced myositis

Frontiers in Immunology(2023)10.3389/fimmu.2023.1238221

N/A

0DataRank · unranked

3 citations

Tracy Tabib, Ying Wang, Timothy B. Oriss, Nicholas A. Young, Robert Lafyatis +4 more

Paula R. Clemens

Indexed papers

Top data-sharing exemplar

Papers